Stock 9926 AKESO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Akeso, Inc.

Equities

9926

KYG0146B1032

Delayed Hong Kong S.E.
Other stock markets
 07:19:18 03/05/2024 BST 		5-day change 1st Jan Change
48.8 HKD 0.00% Intraday chart for Akeso, Inc. +3.94% +5.17%
04-24 Akeso’s Supplemental New Drug Application for Cervical Cancer Drug Accepted by Chinese Regulator MT
04-24 National Medical Products Administration Accepted the Supplemental New Drug Application by Akeso, Inc. for (Cadonilimab, Pd-1/Ctla-4) as First-Line Treatment for Cervical Cancer CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. 9926 Stock
  4. Revisions Akeso, Inc.